ANTH - Anthera Pharmaceuticals, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts0000
Avg. Estimate0000
Low Estimate0000
High Estimate0000
Year Ago EPS0.03-0.58N/AN/A
Revenue EstimateCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
No. of Analysts1111
Avg. EstimateN/AN/AN/A4.78M
Low EstimateN/AN/AN/A4.78M
High EstimateN/AN/AN/A4.78M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History6/29/20179/29/201712/30/20173/30/2018
EPS Est.-1.09-0.91-0.66-0.55
EPS Actual0.03-0.58-0.73-0.57
Difference1.120.33-0.07-0.02
Surprise %102.80%36.30%-10.60%-3.60%
EPS TrendCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Current Estimate0000
7 Days Ago-0.46-0.45-2.19-1.54
30 Days Ago-0.46-0.45-2.19-1.54
60 Days Ago-0.46-0.45-2.19-1.54
90 Days Ago-0.46-0.45-2.19-1.54
EPS RevisionsCurrent Qtr. (Jun 2018)Next Qtr. (Sep 2018)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesANTHIndustrySectorS&P 500
Current Qtr.N/AN/AN/A-0.00
Next Qtr.N/AN/AN/A0.08
Current YearN/AN/AN/A0.03
Next YearN/AN/AN/A0.10
Next 5 Years (per annum)10.00%N/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A